Change in hematologic indices over time in pediatric inflammatory bowel disease treated with azathioprine

Drugs R D. 2010;10(4):213-7. doi: 10.2165/11539930-000000000-00000.

Abstract

Azathioprine leads to changes in mean corpuscular volume (MCV) and white blood cell (WBC) indices reflecting efficacy or toxicity. Understanding the interactions between bone marrow stem cells and azathioprine could highlight abnormal response patterns as forerunners for hematologic malignancies. This study gives a statistical description of factors influencing the relationship between MCV and WBC in children with inflammatory bowel disease treated with azathioprine. We found that leukopenia preceded macrocytosis. Macrocytosis is therefore not a good predictor of leukopenia. Further studies will be necessary to determine the subgroup of patients at increased risk of malignancies based on bone marrow response.

MeSH terms

  • Adolescent
  • Azathioprine / adverse effects*
  • Child
  • Cohort Studies
  • Erythrocyte Indices / drug effects*
  • Female
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Inflammatory Bowel Diseases / blood*
  • Inflammatory Bowel Diseases / drug therapy*
  • Leukocyte Count
  • Leukopenia / chemically induced*
  • Male
  • Methyltransferases / blood
  • Time Factors

Substances

  • Immunosuppressive Agents
  • Methyltransferases
  • thiopurine methyltransferase
  • Azathioprine